SCHEMBL29890070

SCHEMBL29890070

O=Cc1ccc(-c2oc3c(O)c(O)ccc3c(=O)c2O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATP1A1 P05023 2/20 0.54
▸ ATP1B1 P05026 2/20 0.54
▸ ATP1A3 P13637 2/20 0.54
▸ ATP1B2 P14415 2/20 0.54
▸ ATP1A2 P50993 2/20 0.54
▸ ATP1B3 P54709 2/20 0.54
▸ FXYD2 P54710 2/20 0.54
▸ ATP1A4 Q13733 2/20 0.54
▸ NUDT1 P36639 1/20 0.54
▸ TERT O14746 3/20 0.52
▸ APP P05067 2/20 0.49
▸ ABCG2 Q9UNQ0 2/20 0.48
▸ FBP1 P09467 2/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ ACE P12821 1/20 0.46
▸ GAA P10253 3/20 0.45
▸ KDM4E B2RXH2 5/20 0.45
▸ MAPT P10636 5/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ MEN1 O00255 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29904505 0.85 FBP1 (0.61) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL4909482 0.85 FBP1 (0.61) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL29843061 0.84 APP (0.52) APPABCG2GAAKDM4EMAPT
SCHEMBL31438664 0.82 ABCG2 (0.68) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL5569925 0.82 ABCG2 (0.68) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL34972 0.81 TERT (0.76) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL31682973 0.81 TERT (0.76) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL12639988 0.79 MEN1 (0.61) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL25300326 0.75 MEN1 (0.73) GAAKDM4EMAPTALDH1A1MEN1
SCHEMBL21668590 0.75 CDK2 (0.54) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022200542-A1 FLAVONOID POLYAMINES AND THEIR USE TREATING CENTRAL NERVOUS SYSTEM DISORDERS Floratek Pharma SA (CH) 2022-09-29 — — WO disclosed
Send feedback